<SEC-DOCUMENT>0001292814-25-003595.txt : 20251022
<SEC-HEADER>0001292814-25-003595.hdr.sgml : 20251022
<ACCEPTANCE-DATETIME>20251022163359
ACCESSION NUMBER:		0001292814-25-003595
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20251022
DATE AS OF CHANGE:		20251022

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Afya Ltd
		CENTRAL INDEX KEY:			0001771007
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EDUCATIONAL SERVICES [8200]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38992
		FILM NUMBER:		251410528

	BUSINESS ADDRESS:	
		STREET 1:		ALAMEDA OSCAR NIEMEYER, NO. 119
		STREET 2:		15TH FLOOR, VILA DA SERRA
		CITY:			NOVA LIMA, MINAS GERAIS
		STATE:			D5
		ZIP:			34006-056
		BUSINESS PHONE:		55 (31) 3515 7500

	MAIL ADDRESS:	
		STREET 1:		ALAMEDA OSCAR NIEMEYER, NO. 119
		STREET 2:		15TH FLOOR, VILA DA SERRA
		CITY:			NOVA LIMA, MINAS GERAIS
		STATE:			D5
		ZIP:			34006-056
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>afya20251022_6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B>&nbsp;&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0 0 0 6.85pt; text-align: center; text-indent: -6.85pt"><B>REPORT OF FOREIGN
PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0 0 0 6.85pt; text-align: center; text-indent: -6.85pt">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the month of October 2025</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Commission File Number:
001</B></FONT><FONT STYLE="font-size: 12pt">-</FONT><FONT STYLE="font-size: 14pt"><B>38992</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 28pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Afya Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Exact name of registrant as specified in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Rua Para&iacute;ba, No. 330, 17th Floor</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Bairro Funcion&aacute;rios, Belo Horizonte, Minas
Gerais</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Brazil, 30130-917 </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>+55 (31) 3515 7550</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Address of principal executive office)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Indicate by check mark whether the registrant files
or will file annual reports under cover of Form&nbsp;20-F or Form 40-F:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Form 20-F</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid">X</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Form 40-F</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;<BR STYLE="clear: both">
</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>Afya Limited</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">/s/ Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 46%">Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date: October 22, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 12.25pt 0 11.5pt; text-align: center"><B>&nbsp;<BR STYLE="clear: both">
</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; text-align: center"><B>EXHIBIT</B></TD>
    <TD STYLE="width: 91%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="ex99-1.htm">99.1</A></TD>
    <TD><A HREF="ex99-1.htm">Repurchase of the Series A Perpetual Convertible Preferred Shares and Repayment of Afya Participa&ccedil;&otilde;es S.A. Debentures.</A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="afya202510216k_001.jpg" ALT="IR Afya" STYLE="height: 110px; width: 249px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>REPURCHASE OF THE SERIES A PERPETUAL CONVERTIBLE
PREFERRED SHARES AND REPAYMENT OF AFYA PARTICIPA&Ccedil;&Otilde;ES S.A. DEBENTURES</B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>Belo Horizonte, Brazil, October 22, 2025 &ndash;
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (&ldquo;Afya&rdquo; or the &ldquo;Company</B>&rdquo;<B>)</B>, the leading medical education group
and medical practice solutions provider in Brazil, announced today that it has entered into a Share Repurchase Agreement with SBLA Holdco
LLC, an affiliate of Softbank, to repurchase all 150,000 Series A Perpetual Convertible Preferred Shares of a nominal or par value of
US$0.00005 each in the capital of the Company (the &quot;<B>Series A Preferred Shares</B>&quot;) for an aggregate purchase price of R$831.6
million. The transaction is expected to close on November 3, 2025.</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 26, 2021, the Company issued and sold 150,000
Series A Preferred Shares, equivalent to US$150.0 million in Reais, to Softbank. Afya intends to cancel all Series A Preferred Shares
upon completion of the repurchase.</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0 12pt; text-align: justify">Afya also announced today that it has repaid
in full on October 22, 2025, the R$500.0 million aggregate amount outstanding related to the first issuance of debentures by Afya Participa&ccedil;&otilde;es
S.A., a subsidiary of the Company (&ldquo;Afya Brazil&rdquo;).</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0 12pt; text-align: justify">On December 16, 2022, Afya Brazil issued
500,000 debentures, equivalent to R$500.0 million. The debentures were issued with a maturity date of January 15, 2028, with the principal
to be amortized in two equal installments payable on January 15, 2027, and January 15, 2028.</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0 12pt; text-align: justify">The Company will fund the repurchase of
the Series A Preferred Shares and the repayment of the debentures with the proceeds from the commercial notes issued by Afya Brazil on
October 15, 2025, as previously disclosed.</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white"><B>About Afya Limited (Nasdaq: AFYA, B3: A2FY34)</B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Afya is a leading medical education group in Brazil
based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and
physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their
medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to
help doctors enhance their healthcare services through their whole career.</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">Investor Relations Contact:</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">Afya Limited</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white; color: blue"><U>ir@afya.com.br</U></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>afya202510216k_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afya202510216k_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !N /D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ HH
MHH **** "DHK)\2:_!X=TF2[FPTA^6*//+OV'T]:"H0E4DH15VQ-<\4Z7X>V
MK?SXE896)!N<CUQV'UKGS\5M'R0+:]/_  !?\:\MOKZ?4KV:[NY"\TK;F8_R
M^E1S0R6\ACFC:-P 2K#!&1D?H:OE/JJ.1T%%*JVY'T%I6I0ZQID%];;A%,NX
M!A@CL0:N5P?PIU'SM&N;%C\UO+O4?[+?_7!_.N\J&?-XNA["M*GV84444'.%
M075W;V-NT]W-'#$O5Y&  I;JYBL[66XG;;%$A=V] !DUX7XD\1W7B346GN&*
MPJ2(80>$'^/J::5ST,!@)8R35[);L].N?B3X?MY"BSS38_BBB)'YG%4S\5M'
MSQ;7I_X"O^->;Z7X>U36@3I]E+,@X+\!0?3)P*U(?AYXADFC1['RT9@&<RH0
MH]>#3LCV)9;E]+W9SU7FCUC0=<B\0:?]MMX)HH2Q5?- !;'4C!Z=OPK4JMI]
ME#IMA!9VZXBA0(OX=ZLU)\U4<7-\FW0****" HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***2@"*ZN8;.VDN+B01PQ*6=CT %>'>*O$<WB35FN&RMO'
ME8(_[J^OU/4UO_$7Q9_:5T=*L9,VD+?OG4\2..WT'\_I7.>&O#\_B/5TM(LK
M$/FFDQPB_P")Z"J2L?497@XX6D\56T=ON7^;-SX?>$_[9O?[0O8\V-NWRJ1Q
M*X[?0=_R]:D^*>G_ &?7X+Q1\MU%@G_:7C^1%>IV5E!IUE%:6J".&)0J*/2N
M6^)VG?;/#'VA1E[20/\ \!/!_F#^%%]3CH9C*KCXU);/1+R9Q?PVU'[#XKCA
M9L)=H8C]>H_EC\:]DKYULKI[&^@NH^'AD60?@<U]#6\Z7-O%/&<I*@=3[$9%
M$AY]1Y:T:BZK\B6BBN6\2^.K;PUJ*6<UI-.S1B3<C* ,DC'/TJ3QJ5&=:7)3
M5V0?$V_-IX5,*MAKJ58_JH^8_P J\DLK5[Z^@M8_OS2+&/J3BNE\:>,H?%$%
MI%!;S0+ S,P=@=Q( '3\?SK!T2^BTS6K2]GB,L<$@<HO4XZ?KBK6Q]=EU"IA
M\(TU[VKM^1[Y86,.FV,-I;($AA4*HJ>N _X6W8_] RZ_[[6MKPQXTA\47<T$
M%G-#Y*!V9V!')P!Q_GBILSYFK@<3"+J5(NW5G345R7B'Q_;^'M6>QGL+B1E5
M7#JR@,#]?R_"I_#'C>U\37DUM#;2P/''YG[Q@=PSCC'U%%B'@ZZI^U<?=[G3
M44E+2.8**2N?\1>---\-N(;@O-<L-PAB ) ]23P*#2G2G5ER05V=#17':'\0
MX=>U:&PMM-N5>3)+LRX11U)KI-7U2'1M+GOKG/EPKG ZL>P'N318JIAZM*:I
MSC9OH7:*\_\ ^%MV/_0,NO\ OM:/^%MV/_0,NO\ OM:=F=/]F8O_ )]L] HK
MA;?XKZ5)_K[2\BYXP%;^M=+H_B72]=!_L^[21P,F,_*X_ \T6,:N#KT5><&D
M:M%%%(Y@HHHH ***2@ KC/B#XL_L>S_LZR?%[<+\S \Q(>_U/;\ZW/$WB"#P
MYI+W<N&E/RPQY^^WI].YKPR]O)]0O);NZD,DTK;G8]S5)'LY1@/;S]K47NK\
M6):VLU]=Q6ULADFE8(BCN37N7A;PY#X;TE;=,-._S3R8^\W^ Z"L'X=^$O[+
MM1JE\F+R=?W:D<Q(?ZG^7XUV])L>;X_VT_8TW[J_%A5;4[)-1TRYM) -L\3)
M^8JU24CQDVG='SC)&T,KQR##HQ5AZ$<&O9_AYJ/V_P (VRDY>V)@;\.GZ$5Y
MOX\T[^SO%UXJC"3$3K_P+K^N:WOA/J/EZA>:>QXF02H/=>#^A'Y5;V/K,S2Q
M.!55=+/_ #/4JX'Q5X!U#Q!KTM]%=VL<;*JJK;LX [\>N:[ZDJ#YG#XFIAY\
M]-ZG@7B'0I?#NI?8IYXYI-@<F,' SGCGZ5)X;\.7'B:]EMK:6*)HX_,)DSC&
M0.WUJWX^N?M/C._()(C*QC/;"C/ZYKH_A';YEU.YXX5(QZ]S_A5WT/KJV*J4
M\ JS?O67XE7_ (5-J?\ S_V?_CW^%=5X)\(3^&&O'NIH9I)PH4QYX SG.?J*
MZRDJ;GS-?,\17@Z<WH_(\S^+5AB>POU'W@T+G'IR/ZUSO@&^^P^,+(DX28F%
MO^!#C]<5Z/\ $.P^W>$+E@,O;E9E_ X/Z$UXU;3M:W,4Z??B=77Z@YJEL>[E
MC^L8"5)]+K_(^C*6HK:=;FVBGC.4E0.I]B,U)4'R;5B"_O8M.L)[NX;;%"A=
MC["OG_4]0EU74KB]G/[R=RY'IZ#\!Q7H?Q4UW9##H\+<R8EGP>P^Z/SY_ 5P
MWAS1GU[7+>Q7.QCNE8?PH.I_I^-4CZG)Z,</0EB:G7\E_F>B_#'0OL.DOJ<R
MXFO.(\]HQT_,\_E6GXT\.ZAXEM(+6SN8(8$;?(),Y8]N@Z=:Z.*)((4BB4+&
MBA54= !T%.I7/!GC*DL0\0M[Z'E7_"IM3_Y_[/\ )O\ "C_A4VI_\_\ 9_\
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MQKW2Q\+:+I\02WTVVX&"SH'8_4GFK7]CZ=_T#[3_ +\K_A1<;SNBM(TM/D>
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M2-!T5%  _ 5)107*I.7Q.XE%+100%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 -=U1&9V"JHR2>@%>$^*]=;7]?GN@Q\D'RX1Z(.GY]?QK
MW66))XGBE17C<%65AD$'L:SO^$:T7_H%67_?E?\ "FG8]'+L93PDW.4;L\!)
MSU-:VB^&=3UZ=4LK9_+)^:9QA%'U[_05[=%HNFP "+3[1,'(Q"O'Z5=4!1@
M #L*?,>C5S]N-J4+/S,GPWX>MO#>EK:P?.['=+*1@R-Z_3T%:U+14GS\YRJ2
:<Y.[84444$A1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
